Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-067100
Filing Date
2025-05-08
Accepted
2025-05-08 16:37:48
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aclx-20250331.htm   iXBRL 10-Q 1835786
2 EX-10.1 aclx-ex10_1.htm EX-10.1 56380
3 EX-31.1 aclx-ex31_1.htm EX-31.1 14478
4 EX-31.2 aclx-ex31_2.htm EX-31.2 14481
5 EX-32.1 aclx-ex32_1.htm EX-32.1 8377
6 EX-32.2 aclx-ex32_2.htm EX-32.2 8618
  Complete submission text file 0000950170-25-067100.txt   6079198

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aclx-20250331.xsd EX-101.SCH 862014
58 EXTRACTED XBRL INSTANCE DOCUMENT aclx-20250331_htm.xml XML 723586
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41259 | Film No.: 25926929
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)